These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 31400383)

  • 61. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
    Wang L; Li M; Zhang N
    Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RGD(Arg-Gly-Asp) internalized docetaxel-loaded pH sensitive liposomes: Preparation, characterization and antitumor efficacy in vivo and in vitro.
    Zuo T; Guan Y; Chang M; Zhang F; Lu S; Wei T; Shao W; Lin G
    Colloids Surf B Biointerfaces; 2016 Nov; 147():90-99. PubMed ID: 27497073
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy.
    Gu Y; Ma J; Fu Z; Xu Y; Gao B; Yao J; Xu W; Chu K; Chen J
    Int J Nanomedicine; 2019; 14():8805-8818. PubMed ID: 31806973
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model.
    Eldin NE; Abu Lila AS; Kawazoe K; Elnahas HM; Mahdy MA; Ishida T
    Eur J Pharm Sci; 2016 Jan; 81():60-6. PubMed ID: 26415830
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
    Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
    Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
    [No Abstract]   [Full Text] [Related]  

  • 67. Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cells.
    Ernsting MJ; Tang WL; MacCallum N; Li SD
    Bioconjug Chem; 2011 Dec; 22(12):2474-86. PubMed ID: 22014112
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quantitative and high drug loading of self-assembled prodrug with defined molecular structures for effective cancer therapy.
    Tang J; Zeng Z; Yan J; Chen C; Liu J; Feng X
    J Control Release; 2019 Aug; 307():90-97. PubMed ID: 31185233
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives.
    van Borssum Waalkes M; van Galen M; Morselt H; Sternberg B; Scherphof GL
    Biochim Biophys Acta; 1993 May; 1148(1):161-72. PubMed ID: 8499464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nanoscale Lipophilic Prodrugs of Dexamethasone with Enhanced Pharmacokinetics.
    Lorscheider M; Tsapis N; Simón-Vázquez R; Guiblin N; Ghermani N; Reynaud F; Canioni R; Abreu S; Chaminade P; Fattal E
    Mol Pharm; 2019 Jul; 16(7):2999-3010. PubMed ID: 31117740
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
    Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mixed molecular weight copolymer nanoparticles for the treatment of drug-resistant tumors: formulation development and cytotoxicity.
    Wan CPL; Letchford K; Leung D; Jackson JK; Burt HM
    J Pharm Sci; 2014 Dec; 103(12):3966-3976. PubMed ID: 25318668
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin.
    Jiang SP; He SN; Li YL; Feng DL; Lu XY; Du YZ; Yu HY; Hu FQ; Yuan H
    Int J Nanomedicine; 2013; 8():3141-50. PubMed ID: 23990722
    [TBL] [Abstract][Full Text] [Related]  

  • 75. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.
    Xu WW; Liu DY; Cao YC; Wang XY
    Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy.
    Fan Y; Wang Q; Lin G; Shi Y; Gu Z; Ding T
    Acta Biomater; 2017 Oct; 62():257-272. PubMed ID: 28859899
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of glycosylated docetaxel-encapsulated liposomes prepared by remote loading under solubility gradient.
    Shigehiro T; Zhai W; Vaidyanath A; Masuda J; Mizutani A; Kasai T; Murakami H; Hamada H; Salomon DS; Mikuni K; Seno Y; Mandai T; Seno M
    J Microencapsul; 2016; 33(2):172-82. PubMed ID: 26885749
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Liposomal Formulation of a Melphalan Lipophilic Prodrug: Studies of Acute Toxicity, Tolerability, and Antitumor Efficacy.
    Tretiakova D; Svirshchevskaya E; Onishchenko N; Alekseeva A; Boldyrev I; Kamyshinsky R; Natykan A; Lokhmotov A; Arantseva D; Shobolov D; Vodovozova E
    Curr Drug Deliv; 2020; 17(4):312-323. PubMed ID: 32056524
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer.
    Tian J; Min Y; Rodgers Z; Wan X; Qiu H; Mi Y; Tian X; Wagner KT; Caster JM; Qi Y; Roche K; Zhang T; Cheng J; Wang AZ
    Nanomedicine; 2017 Apr; 13(3):1301-1307. PubMed ID: 27884641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.